These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29391917)

  • 1. Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept.
    Baum RP; Langbein T; Singh A; Shahinfar M; Schuchardt C; Volk GF; Kulkarni H
    Nucl Med Mol Imaging; 2018 Feb; 52(1):80-81. PubMed ID: 29391917
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Junqueira MZ; Rocha NH; Sapienza MT
    Radiol Bras; 2021; 54(3):171-176. PubMed ID: 34108764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection.
    Mueller J; Langbein T; Mishra A; Baum RP
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
    Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
    Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of
    Belli ML; Sarnelli A; Mezzenga E; Cesarini F; Caroli P; Di Iorio V; Strigari L; Cremonesi M; Romeo A; Nicolini S; Matteucci F; Severi S; Paganelli G
    Front Oncol; 2020; 10():531660. PubMed ID: 33251129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of External Cooling on
    Yilmaz B; Nisli S; Ergul N; Gursu RU; Acikgoz O; Çermik TF
    J Nucl Med; 2019 Oct; 60(10):1388-1393. PubMed ID: 30850503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing
    Rathke H; Kratochwil C; Hohenberger R; Giesel FL; Bruchertseifer F; Flechsig P; Morgenstern A; Hein M; Plinkert P; Haberkorn U; Bulut OC
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):139-147. PubMed ID: 30151743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [
    Nail V; Louis B; Moyon A; Chabert A; Balasse L; Fernandez S; Hache G; Garrigue P; Taïeb D; Guillet B
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with
    Langbein T; Kulkarni HR; Schuchardt C; Mueller D; Volk GF; Baum RP
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMA PET/CT as a predictive tool for subregional importance estimates in the parotid gland.
    Sample C; Rahmim A; Benard F; Wu J; Clark H
    Biomed Phys Eng Express; 2024 Feb; 10(2):. PubMed ID: 38271732
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving
    Sathekge M; Bruchertseifer F; Vorster M; Lawal IO; Knoesen O; Mahapane J; Davis C; Reyneke F; Maes A; Kratochwil C; Lengana T; Giesel FL; Van de Wiele C; Morgenstern A
    J Nucl Med; 2020 Jan; 61(1):62-69. PubMed ID: 31101746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.
    Mohan V; Bruin NM; Tesselaar MET; de Boer JP; Vegt E; Hendrikx JJMA; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
    EJNMMI Res; 2021 Mar; 11(1):25. PubMed ID: 33710423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of
    Soeda F; Watabe T; Naka S; Liu Y; Horitsugi G; Neels OC; Kopka K; Tatsumi M; Shimosegawa E; Giesel FL; Hatazawa J
    J Nucl Med; 2019 Nov; 60(11):1594-1599. PubMed ID: 30902876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands.
    Julian W; Sergeeva O; Cao W; Wu C; Erokwu B; Flask C; Zhang L; Wang X; Basilion J; Yang S; Lee Z
    Cancer Biother Radiopharm; 2024 Sep; ():. PubMed ID: 39268679
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of eating on the uptake of PSMA ligands in the salivary glands.
    Mohan V; Bruin NM; van de Kamer JB; Sonke JJ; Vogel WV
    EJNMMI Res; 2021 Sep; 11(1):95. PubMed ID: 34568982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results on response assessment using
    Seitz AK; Rauscher I; Haller B; Krönke M; Luther S; Heck MM; Horn T; Gschwend JE; Schwaiger M; Eiber M; Maurer T
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):602-612. PubMed ID: 29185010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Dosimetry for
    Okamoto S; Thieme A; Allmann J; D'Alessandria C; Maurer T; Retz M; Tauber R; Heck MM; Wester HJ; Tamaki N; Fendler WP; Herrmann K; Pfob CH; Scheidhauer K; Schwaiger M; Ziegler S; Eiber M
    J Nucl Med; 2017 Mar; 58(3):445-450. PubMed ID: 27660138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.
    Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.